DIATRIZOATE MEGLUMINE - Generic Drug Details

What are the generic drug sources for diatrizoate meglumine and what is the scope of patent protection?

Diatrizoate meglumine is the generic ingredient in thirty-two branded drugs marketed by Bayer Hlthcare, Bracco, Ge Healthcare, Intl Medication, Mallinckrodt, Liebel-flarsheim, Anda Repository, and Annora Pharma, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for diatrizoate meglumine. One supplier is listed for this compound.

Summary for DIATRIZOATE MEGLUMINE

US Patents:	0
Tradenames:	32
Applicants:	8
NDAs:	22
Drug Master File Entries:	4
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	32
Clinical Trials:	1
Patent Applications:	1,319
What excipients (inactive ingredients) are in DIATRIZOATE MEGLUMINE?	DIATRIZOATE MEGLUMINE excipients list
DailyMed Link:	DIATRIZOATE MEGLUMINE at DailyMed

Recent Clinical Trials for DIATRIZOATE MEGLUMINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lawson Health Research Institute	Phase 4

See all DIATRIZOATE MEGLUMINE clinical trials

Pharmacology for DIATRIZOATE MEGLUMINE

Drug Class	Radiographic Contrast Agent
Mechanism of Action	X-Ray Contrast Activity

Medical Subject Heading (MeSH) Categories for DIATRIZOATE MEGLUMINE

Contrast Media

US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	UROVIST CYSTO PEDIATRIC	diatrizoate meglumine	SOLUTION;URETERAL	087731-001	Sep 23, 1982		DISCN	No	No
Anda Repository	DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM	diatrizoate meglumine; diatrizoate sodium	SOLUTION;ORAL, RECTAL	214201-001	Jun 27, 2022	AA	RX	No	No
Bracco	RENOVIST II	diatrizoate meglumine; diatrizoate sodium	INJECTABLE;INJECTION	010040-019	Approved Prior to Jan 1, 1982		DISCN	No	No